TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.
Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, Chang SS, Yamaguchi H, Lee HH, Ke B, Hsu JM, Chan LC, Hortobagyi GN, Yang L, Lin C, Yu D, Hung MC.
Jiang Z, et al. Among authors: hung mc.
J Clin Invest. 2021 Apr 15;131(8):e139434. doi: 10.1172/JCI139434.
J Clin Invest. 2021.
PMID: 33855973
Free PMC article.